EPO and nervous system disorder: Since the cell-based delivery of EPO to the damaged local brain area has not been demonstrated in the animal model of neurological disease, we considered to establish an EPO-overexpressing fibroblast cell line in our study as a material which might represent a short-term, high-dose, and regional therapeutic concept for future in vivo study on the treatment of neurological diseases.